Loading…
PolyPid Ltd. is projected to rise to $7.39 by 2027, a +41% move from its current price of $5.23. PYPD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.06 | $5.23 | $5.41 | +0.03% |
| Jul 14 | $4.99 | $5.23 | $5.49 | +0.05% |
| Jul 15 | $4.94 | $5.23 | $5.55 | +0.08% |
| Jul 16 | $4.89 | $5.24 | $5.60 | +0.10% |
| Jul 17 | $4.85 | $5.24 | $5.65 | +0.13% |
| Jul 18 | $4.82 | $5.24 | $5.69 | +0.15% |
| Jul 19 | $4.79 | $5.24 | $5.73 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.79 | $5.24 | $5.73 | +0.18% |
| Week 2 | $4.62 | $5.25 | $5.96 | +0.36% |
| Week 3 | $4.50 | $5.26 | $6.14 | +0.54% |
| Week 4 | $4.40 | $5.27 | $6.30 | +0.72% |
| Week 5 | $4.32 | $5.28 | $6.45 | +0.90% |
| Week 6 | $4.24 | $5.29 | $6.58 | +1.08% |
| Week 7 | $4.18 | $5.30 | $6.71 | +1.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PolyPid Ltd. is a biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.
The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. PolyPid has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors.
PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
PolyPid Ltd. (PYPD) is trading at $5.58 per share, with a market capitalization of $106.99M and a rank of 4125. These figures place it among smaller-cap biopharma equities with a development-stage profile. The near-term forecast for 2026 shows a min of $4.08, an avg of $5.58, and a max of $7.76, with a neutral sentiment and 0% ROI.
A major floor 23.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.0% below — buyers have tended to step in here.
The nearest ceiling, 6.7% above — a clean break opens room to run.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key PYPD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PYPD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.35 | Sell | $5.27 | Sell |
| MA 10 | $5.16 | Buy | $5.17 | Buy |
| MA 20 | $4.95 | Buy | $5.03 | Buy |
| MA 50 | $4.75 | Buy | $4.81 | Buy |
| MA 100 | $4.55 | Buy | $4.62 | Buy |
| MA 200 | $4.25 | Buy | $4.34 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.19 | Neutral |
| Stoch RSI (14) | 45.71 | Neutral |
| CCI (20) | 72.67 | Neutral |
| Williams %R (14) | -34.65 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 4.81 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 65.35 | Neutral |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 0.49 | Buy |
| Ultimate (7,14,28) | 56.32 | Neutral |
| Momentum (10) | 0.66 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 5.38 | Sell |
| ADX (14) | 13.66 | Neutral |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is described as bullish. RSI14 is 70, indicating strong relative strength. The stock trades above the SMA50 of $4.69 and the SMA200 of $4.22, suggesting upside momentum.
A support level exists at $4.50 and a resistance level at $5.58. The 30-day price range spans from $4.44 to $7.01, and the stock exhibits an annualized volatility of 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.08 | $5.23 | $7.21 | 0% | Neutral | |
| $5.75 | $7.39 | $10.11 | +41% | Bullish | |
| $6.47 | $8.61 | $12.33 | +65% | Bullish | |
| $6.30 | $8.64 | $12.80 | +65% | Bullish | |
| $6.71 | $9.45 | $14.41 | +81% | Bullish | |
| $7.31 | $10.54 | $16.48 | +102% | Bullish | |
| $9.01 | $13.29 | $21.26 | +154% | Bullish | |
| $10.94 | $16.48 | $26.89 | +215% | Bullish | |
| $11.32 | $17.41 | $28.94 | +233% | Bullish | |
| $12.03 | $18.86 | $31.90 | +261% | Bullish | |
| $19.25 | $33.03 | $60.00 | +531% | Bullish | |
| $24.96 | $50.27 | $101.23 | +861% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.08 | $5.23 | $6.52 | +0.00% |
| August 2026 | $4.62 | $5.48 | $6.71 | +4.86% |
| September 2026 | $4.47 | $5.35 | $6.64 | -2.38% |
| October 2026 | $4.55 | $5.49 | $6.89 | +2.51% |
| November 2026 | $4.68 | $5.69 | $7.21 | +3.67% |
| December 2026 | $4.61 | $5.64 | $7.21 | -0.86% |
Click any year to see its month-by-month PYPD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PYPD to range from $4.08 to $7.21 through 2026. The $5.23 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PYPD price prediction for 2027 points to an average of $7.39 (low $5.75, high $10.11) — a potential gain of +41% on today's $5.23. Buyers look set to stay in control over this stretch.
In 2028, PYPD is projected to trade between $6.47 and $12.33, averaging $8.61 — a potential gain of +65% from today's $5.23. That is up +17% on the projected 2027 average. Momentum favours further upside here.
PolyPid Ltd.'s 2029 outlook centres on $8.64, within a $6.30 to $12.80 range. That is up 0% on the projected 2028 average. That marks a +65% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, PYPD could reach as high as $14.41, with a base case around $9.45 and support toward $6.71 — roughly +81% from $5.23. Momentum favours further upside here.
Expect PYPD to range from $7.31 to $16.48 through 2031. The $10.54 average target implies a +102% move from current prices. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The PYPD price prediction for 2032 points to an average of $13.29 (low $9.01, high $21.26) — a potential gain of +154% on today's $5.23. Momentum favours further upside here.
In 2033, PYPD is projected to trade between $10.94 and $26.89, averaging $16.48 — a potential gain of +215% from today's $5.23. That is up +24% on the projected 2032 average. Buyers look set to stay in control over this stretch.
PolyPid Ltd.'s 2034 outlook centres on $17.41, within a $11.32 to $28.94 range. That is up +6% on the projected 2033 average. That marks a +233% change versus current levels. Momentum favours further upside here.
By 2035, PYPD could reach as high as $31.90, with a base case around $18.86 and support toward $12.03 — roughly +261% from $5.23. Buyers look set to stay in control over this stretch.
Expect PYPD to range from $19.25 to $60.00 through 2040. The $33.03 average target implies a +531% move from current prices. That is up +75% on the projected 2035 average. Momentum favours further upside here.
The PYPD price prediction for 2050 points to an average of $50.27 (low $24.96, high $101.23) — a potential gain of +861% on today's $5.23. Buyers look set to stay in control over this stretch.
Investing $1,000 in PYPD today (≈ 191.204589 PYPD) could be worth
$9,611.18
+$8,611.18 (+861%) by 2050 · US Dollar
Based on the average projected PYPD price of $50.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PYPDwould be worth at today's price.
$1,000 invested in PYPD on Jul 10, 2025 (≈ 288.184436 PYPD) would be worth
$1,507.2
+$507.2 (+50.7%) today · 1.51× · US Dollar
Based on a PYPD entry price of $3.47 vs. today's $5.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.02 | $1,041.83 | +4.2% |
| 1 month ago | $4.51 | $1,159.65 | +16.0% |
| 3 months ago | $4.31 | $1,213.46 | +21.3% |
| 6 months ago | $4.65 | $1,124.73 | +12.5% |
| 1 year ago | $3.47 | $1,507.2 | +50.7% |
| All time (5.0y) ago | $244.2 | $21.42 | -97.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PYPD forecast.
Our base-case forecast reaches $10.00 around 2031.
Implied market cap at $10.00: $191.74M
The multi-year forecast shows a bullish trajectory with rising averages and ROIs across the years. In 2027 the avg price is forecast at $8.07 with a 44.7% ROI; by 2028 the avg is $9.49 with a 70.1% ROI; 2029 is $9.48 at 70% ROI; 2030 is $10.67 at 91.2% ROI; 2031 is $12.09 at 116.7% ROI; 2032 is $15.38 at 175.6% ROI; 2033 is $19.33 at 246.3% ROI; 2034 is $20.36 at 264.9% ROI; 2035 is $22.05 at 295.2% ROI. The outlook strengthens further into 2040 with an avg of $39.96 and a 616.1% ROI, and culminates in 2050 with an avg of $61.76 and a 1006.9% ROI.
These figures imply substantial upside potential over the long term, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $10.67 with a min of $7.53 and a max of $16.37; ROI 91.2%; sentiment bullish.
Near term is neutral for 2026 with an avg of $5.58 and 0% ROI; the forecast posts a bullish path from 2027 onward, with rising averages and ROIs (e.g., 2027 avg $8.07, ROI 44.7%; 2030 avg $10.67, ROI 91.2%; 2040 avg $39.96, ROI 616.1%; 2050 avg $61.76, ROI 1006.9%). These are estimates, not guarantees.
Yes. The forecast shows 2033 avg $19.33 and 2034 avg $20.36, with 2035 avg $22.05, indicating a potential move through $20 in the mid-2030s.
Current price: $5.58. Market capitalization: $106.99M.
The 30-day picture is bullish with RSI14 at 70. Price is above SMA50 ($4.69) and SMA200 ($4.22). Support is at $4.50 and resistance at $5.58. The 30-day range is $4.44 to $7.01, and annualized volatility is 70%.
PolyPid Ltd. Community Discussion
0Share your PolyPid Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.